Gadolinium-Chelate

DRUG5 trials

Sponsors

Royal Marsden NHS Foundation Trust, University College London Hospitals, M.D. Anderson Cancer Center, ECOG-ACRIN Cancer Research Group, Ohio State University Comprehensive Cancer Center

Conditions

Borderline Resectable Pancreatic Ductal AdenocarcinomaBreast CancerGlioblastoma, IDH-WildtypeMalignant Solid NeoplasmProstate Cancer

Phase 1

DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer

Not yet recruitingNCT07705919

Ohio State University Comprehensive Cancer CenterBorderline Resectable Pancreatic Ductal Adenocarcinoma

Start: 2026-09-01End: 2027-12-31Target: 50Updated: 2026-07-15

Phase 2

Dutasteride in Treating Patients With Prostate Cancer

University College London HospitalsProstate Cancer

Start: 2010-06-30Target: 42Updated: 2013-08-26

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

RecruitingNCT06319027

ECOG-ACRIN Cancer Research GroupGlioblastoma, IDH-Wildtype

Start: 2024-04-11End: 2027-05-31Target: 100Updated: 2026-06-18

Unknown Phase

Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer

Royal Marsden NHS Foundation TrustBreast Cancer

Start: 2007-11-30Target: 20Updated: 2013-08-26

Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis

CompletedNCT04870645

M.D. Anderson Cancer CenterMalignant Solid Neoplasm

Start: 2021-03-30End: 2023-08-29Updated: 2024-11-06

Related Papers

An Accelerated Spectroscopic MRI Metabolite Quantification Based on a Deep Learning Method for Radiation Therapy Planning in Brain Tumor Patients

Cancers2025-01-271 citations